Efficacy of supplementation with B vitamins for stroke prevention: A network meta-analysis of randomized controlled trials

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Dong, Hongli ^a   Pi, Fuhua ^a   Ding, Zan ^a   Chen, Wei ^b   Pang, Shaojie ^a   Dong, Wenya ^a   Zhang, Qingying ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

^b THE SECOND AFFILIATED HOSPITAL OF SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; NICOTINIC ACID; PLACEBO; PYRIDOXINE; VITAMIN B GROUP; VITAMIN B COMPLEX;

ARTICLE; BRAIN HEMORRHAGE; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; DRUG EFFICACY; HUMAN; META ANALYSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; VITAMIN SUPPLEMENTATION; BAYES THEOREM; DIETARY SUPPLEMENT; RISK; STROKE; TREATMENT OUTCOME;

BAYES THEOREM; DIETARY SUPPLEMENTS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK; STROKE; TREATMENT OUTCOME; VITAMIN B 12; VITAMIN B 6; VITAMIN B COMPLEX;

EID: 84944729943     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137533     Document Type: Article

References (41)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Globaland regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012; 380 (9859):2095-128. doi: 10.1016/S0140-6736(12)61728-0 PMID: 23245604
2. Strong K, Mathers C, Bonita R. Preventing stroke: saving lives around the world. Lancet Neurol. 2007; 6(2):182-7. doi: 10.1016/S1474-4422(07)70031-5 PMID: 17239805
3. Towfighi A, Markovic D, Ovbiagele B. Pronounced association of elevated serum homocysteine with stroke in subgroups of individuals: a nationwide study. J Neurol Sci. 2010; 298(1-2):153-7. doi: 10.1016/j.jns.2010.07.013 PMID: 20810133
4. Sacco RL, Anand K, Lee HS, Boden-Albala B, Stabler S, Allen R, et al. Homocysteine and the risk of ischemic stroke in a triethnic cohort: the NOrthern MAnhattan Study. Stroke.2004; 35(10):2263-9. doi: 10.1161/01.STR.0000142374.33919.92 PMID: 15345803
5. Bos MJ, van Goor ML, Koudstaal PJ, Dippel DW. Plasma homocysteine is a risk factor for recurrent vascular events in young patients with an ischaemic stroke or TIA. J Neurol. 2005; 252(3):332-7. doi: 10.1007/s00415-005-0647-9 PMID: 15739046
6. Virtanen JK, Voutilainen S, Happonen P, Alfthan G, Kaikkonen J, Mursu J, et al. Serum homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil. 2005; 12(4):369-75 PMID: 16079645
7. McNulty H, Pentieva K, Hoey L, Ward M. Homocysteine, B-vitamins and CVD. Proc Nutr Soc. 2008; 67(2):232-7. doi: 10.1017/S0029665108007076 PMID: 18412997
8. Lumley T. Network meta-analysis for indirect treatment comparisons. Stat Med. 2002; 21(16):2313-24. doi: 10.1002/sim.1201
9. Salanti G, Higgins JP, Ades AE, Ioannidis JP. Evaluation of networks of randomized trials. Stat Methods Med Res. 2008; 17(3):279-301 doi: 10.1177/0962280207080643 PMID: 17925316
10. Caldwell DM, Ades AE, Higgins JP. Simultaneous comparison of multiple treatments: combining direct and indirect evidence. Bmj. 2005; 331(7521):897-900. doi: 10.1136/bmj.331.7521.897 PMID: 16223826
11. Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials. 1996; 17(1):1-12. doi: 10.1016/0197-2456(95)00134-4 PMID: 8721797
12. Higgins JP, Thompson SG, Deeks JJ, Altman DG, et al. Measuring inconsistency in meta-analyses. Bmj. 2003; 327:557-60. doi: 10.1136/bmj.327.7414.557 PMID: 12958120
13. Lu G, Ades AE. Combination of direct and indirect evidence in mixed treatment comparisons. Stat Med. 2004; 23(20):3105-24. doi: 10.1002/sim.1875 PMID: 15449338
14. Spiegelhalter DJ, Best NG, Carlin BR, van der Linde A. Bayesian measures of model complexity and fit. Journal of the Royal Statistical Society Series B-Statistical Methodology. 2002; 64(4):583-639. doi: 10.1111/1467-9868.00353
15. Salanti G, Marinho V, Higgins JP. A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered. J Clin Epidemiol. 2009; 62(8):857-64. doi: 10.1016/j.jclinepi.2008.10.001 PMID: 19157778
16. Saposnik G, Ray JG, Sheridan P, McQueen M, Lonn E, et al. Homocysteine-lowering therapy and stroke risk, severity, and disability: additional findings from the HOPE 2 trial. Stroke. 2009; 40(4):1365-72. doi: 10.1161/STROKEAHA.108.529503 PMID: 19228852
17. Ebbing M, Bonaa KH, Arnesen E, Ueland PM, Nordrehaug JE, Rasmussen K, et al. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials. J Intern Med. 2010; 268(4):367-82. doi: 10.1111/j.1365-2796.2010.02259.x PMID: 20698927
18. Galan P, Kesse-Guyot E, Czernichow S, Briancon S, Blacher J, Hercberg S, et al. Effects of B vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. Bmj. 2010; 341:c6273. doi: 10.1136/bmj.c6273 PMID: 21115589
19. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, et al. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Jama. 2008; 299(17):2027-36. doi: 10.1001/jama.299.17.2027 PMID: 18460663
20. Hankey GJ, Eikelboom JW, Yi Q, Lees KR, Chen C, Xavier D, et al. Antiplatelet therapy and the effects of b vitamins in patients with previous stroke or transient ischaemic attack: A post-hoc subanalysis of vitatops, a randomised, placebo-controlled trial. Lancet Neurol. 2012; 11(6):512-520. doi: 10.1016/S1474-4422(12)70091-1 PMID: 22554931
21. Hankey GJ, Eikelboom JW, Baker RI, Gelavis A, Hickling SC, Jamrozik K, et al. B vitamins in patients with recent transient ischaemic attack or stroke in the VITAmins TO Prevent Stroke (VITATOPS) trial: a randomised, double-blind, parallel, placebo-controlled trial. Lancet Neurol. 2010; 9(9):855-65. doi: 10.1016/S1474-4422(10)70187-3 PMID: 20688574
22. Landray MJ, Haynes R, Hopewell JC, Parish S, Aung T, Tomson J, et al. Effects of extended-release niacin with laropiprant in high-risk patients. N Engl J Med. 2014; 371(3):203-12. doi: 10.1056/NEJMoa1300955 PMID: 25014686
23. Ebbing M, Bleie O, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, et al. Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography: a randomized controlled trial. Jama. 2008; 300(7):795-804. doi: 10.1001/jama.300.7.795 PMID: 18714059
24. Cole BF, Baron JA, Sandler RS, Haile RW, Ahnen DJ, Bresalier RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Jama. 2007; 297(21):2351-9. doi: 10.1001/jama.297.21.2351 PMID: 17551129
25. Armitage JM, Bowman L, Clarke RJ, Wallendszus K, Bulbulia R, Rahimi K, et al. Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placeboon mortality and major morbidity in myocardial infarction survivors: a randomized trial. Jama. 2010; 303(24): 2486-94. doi: 10.1001/jama.2010.840 PMID: 20571015
26. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. Jama. 2007; 298(10): 1163-70. doi: 10.1001/jama.298.10.1163 PMID: 17848650
27. House AA, Eliasziw M, Cattran DC, Churchill DN, Oliver MJ, Fine A, et al. Effect of B-vitamin therapy on progression of diabetic nephropathy: a randomized controlled trial. Jama. 2010; 303(16):1603-9. doi: 10.1001/jama.2010.490 PMID: 20424250
28. Clofibrate and niacin in coronary heart disease. Jama. 1975; 231(4):360-81. doi: 10.1001/jama.1975.03240160024021 PMID: 1088963
29. Bostom AG, Carpenter MA, Kusek JW, Levey AS, Hunsicker L, Pfeffer MA, et al. Homocysteine-lowering and cardiovascular disease outcomes in kidney transplant recipients: primary results from the Folic Acid for Vascular Outcome Reduction in Transplantation trial. Circulation. 2011; 123(16):1763-70. doi: 10.1161/Circulationaha.110.000588 PMID: 21482964
30. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, et al. Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med. 2006; 354(15):1578-88. doi: 10.1056/NEJMoa055227 PMID: 16531614
31. Imasa MS, Gomez NT, Nevado JB Jr. Folic acid-based intervention in non-ST elevation acute coronary syndromes. Asian Cardiovasc Thorac Ann. 2009; 17(1):13-21. doi: 10.1177/0218492309102494 PMID: 19515873
32. Zoungas S, McGrath BP, Branley P, Kerr PG, Muske C, Wolfe R, et al. Cardiovascular morbidity and mortality in the Atherosclerosis and Folic Acid Supplementation Trial (ASFAST) in chronic renal failure: a multicenter, randomized, controlled trial. J Am Coll Cardiol. 2006; 47(6):1108-16. doi: 10.1016/j.jacc.2005.10.064 PMID: 16545638
33. Huang T, Chen Y, Yang B, Yang J. Wahlqvist ML, Li D. Meta-analysis of B vitamin supplementation on plasma homocysteine, cardiovascular and all-cause mortality. Clin Nutr. 2012; 31(4):448-54. doi: 10.1016/j.clnu.2011.01.003 PMID: 22652362
34. Ji Y, Tan S, Xu Y, Chandra A, Shi C, Song B, et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease: a meta-analysis. Neurology. 2013; 81(15):1298-307. doi: 10.1212/WNL.0b013e3182a823cc PMID: 24049135
35. Zhang C, Chi FL, Xie TH, Zhou YH. Effect of B-vitamin supplementation on stroke: a meta-analysis of randomized controlled trials. PLoS One. 2013; 8(11):e81577. doi: 10.1371/journal.pone.0081577 PMID: 24282609
36. Van Guelpen B, Hultdin J, Johansson I, Stegmayr B, Hallmans G, Nilsson TK, et al. Folate, vitamin B12, and risk of ischemic and hemorrhagic stroke: a prospective, nested case-referent study of plasma concentrations and dietary intake. Stroke. 2005; 36(7):1426-31. doi: 10.1161/01.STR.0000169934.96354.3a PMID: 15933256
37. Wang X, Qin X, Demirtas H, Li J, Mao G, Huo Y, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet. 2007; 369(9576):1876-82. doi: 10.1016/S0140-6736(07)60854-X PMID: 17544768
38. Rimm EB, Willett WC, Hu FB, Sampson L, Colditz GA, Manson JE, et al. Folate and vitamin B6from diet and supplements in relation to risk of coronary heart disease among women. Jama. 1998; 279(5):359-64. doi: 10.1001/jama.279.5.359 PMID: 9459468
39. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Bmj. 2002; 325(7374):1202. doi: 10.1136/bmj.325.7374.1202 PMID: 12446535
40. Nygard O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr. 1998; 67(2):263-70.PMID: 9459374
41. Selhub J, Jacques PF, Rosenberg IH, Rogers G, Bowman BA, Gunter EW, et al. Serum total homocysteine concentrations in the third National Health and Nutrition Examination Survey (1991-1994): population reference ranges and contribution of vitamin status to high serum concentrations. Ann Intern Med. 1999; 131(5):331-9 PMID: 10475885